Fairvalue-Calculator Fairvalue-Calculator

CareTrust REIT, Inc (CTRE) Fair Value & Analysis

Real Estate · US · Market cap $8.8B

Price$39.40
Fair Value$23.07
Upside-41.4%
Quality95/100
Evidence: High Range $17.30 – $28.83

Analysis

CareTrust REIT, Inc (CTRE) currently trades at $39.40, while our model-based Fair Value estimate is $23.07 — implying the stock looks roughly 41.4% overvalued today. We read business quality at 95/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

CareTrust REIT, Inc. is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, senior housing and other healthcare-related properties. As of December 31, 2025, CareTrust REIT owned, directly or indirectly in consolidated joint ventures, and leased to independent operators, 407 skilled nursing facilities (each, a SNF), senior housing communities and other properties consisting of 37,628 operational beds and units located in 32 states and the United Kingdom, with the highest concentration of properties by rental income located in California, the U.K., Texas, and Tennessee. As of December 31, 2025, we also had other real estate related investments consisting of four preferred equity investments, 16 real estate secured loans receivable and five mezzanine loans receivable with a carrying value of 899.3 million US dollars and one financing receivable with a carrying value of 92.2 million US dollars. CareTrust…

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.